Researchers discover therapy to treat drug-resistant acute lymphoblastic leukemia

Acute lymphoblastic leukemia accounts for one in five adult leukemias, and is the most common pediatric cancer in the United States. While new immune therapies have helped improve survival rates, some patients are unresponsive to existing treatment regimens. In addition, drug-related toxicities and drug resistance are rampant for these patients, Continue Reading

FAKE MEDICINE: “Randomized” drug trial protocols are frequently altered by industry sponsors who selectively remove participants that get sick

When it comes to making and approving pharmaceutical drugs, the science and procedure behind the process is readily corruptible. It can be manipulated to fulfill the wishes of pharmaceutical companies. A team of researchers from the Nordic Cochrane Centre in Copenhagen has exposed widespread corruption in drug trial protocols. The research, Continue Reading

Popular FDA-approved morning sickness drug barely has any effect on pregnant women, study finds

The morning sickness drug Diclegis may not be as effective as previously thought, a study published in the journal PLOS ONE revealed. The researchers discussed that the drug, which received approval from the U.S. Food and Drug Administration (FDA) in 2013, did not fare better than a placebo pill in improving symptoms of Continue Reading